Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.
Jayalath VH, Assel M, Iyer G, Niglio S, Bochner BH, Dalbagni G, Donat SM, Herr HW, Cha EK, Donahue TF, Pietzak EJ, Hakimi AA, Kim K, Al-Ahmadie HA, Vargas HA, Ghafoor S, Benfante NE, Rodriguez DV, Meyerson AR, Meraney AM, Shichman SJ, Kamradt JM, Nair SG, Baccala AA Jr, Palyca P, Lash BW, Rizvi MA, Swanson SK, Muina AF, Apolo AB, Rosenberg JE, Bajorin DF, Coleman JA.
Jayalath VH, et al. Among authors: rodriguez dv.
Eur Urol. 2026 Feb;89(2):108-113. doi: 10.1016/j.eururo.2025.08.012. Epub 2025 Sep 25.
Eur Urol. 2026.
PMID: 41006098
Free article.
Clinical Trial.